<DOC>
	<DOC>NCT00465959</DOC>
	<brief_summary>To assess the effect of a single dose of TrIP on pulmonary function in patients with COPD</brief_summary>
	<brief_title>Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Trospium chloride</mesh_term>
	<criteria>Male or female COPD patients between the ages of 40 and 80 years Smoking history of at least 10 pack years Not currently using (or able to wash out of) any long acting bronchodilators Candidate on a waiting list for surgery while on study Using longterm oxygen therapy Hospitalization for COPD exacerbation</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>COPD</keyword>
</DOC>